Mutations in Hedgehog pathway genes in fetal rhabdomyomas

Journal of Pathology

Volumn 231, Issue 1, 2013, Pages 44-52

  Hettmer, Simone ^a,b,c   Teot, Lisa A ^c   Van Hummelen, Paul ^d   MacConaill, Laura ^d   Bronson, Roderick T ^e   Dall'Osso, Claudia ^a   Mao, Junhao ^f   McMahon, Andrew P ^g   Gruber, Peter J ^h   Grier, Holcombe E ^c   Rodriguez Galindo, Carlos ^c   Fletcher, Christopher D ⁱ   Wagers, Amy J ^a,b  

^a Harvard University   (United States)

^b JOSLIN DIABETES CENTER   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e TUFTS UNIVERSITY   (United States)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Fetal rhabdomyoma; Hedgehog signalling; PTCH1

Indexed keywords

PROTEIN PATCHED 1; SONIC HEDGEHOG PROTEIN;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RHABDOMYOMA;

EID: 84885110343     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4229     Document Type: Article

References (21)

1. Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001; 15: 3059-3087.
2. Chari NS, McDonnell TJ. The sonic hedgehog signaling network in development and neoplasia. Adv Anat Pathol 2007; 14: 344-352.
3. Corcoran RB, Scott MP. A mouse model for medulloblastoma and basal cell nevus syndrome. J Neurooncol 2001; 53: 307-318.
4. Mao J, Ligon KL, Rakhlin EY, et al. A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res 2006; 66: 10171-10178.
5. Hahn H, Wojnowski L, Zimmer AM, et al. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat Med 1998; 4: 619-622.
6. Gerber AN,Wilson CW, Li YJ, et al. The hedgehog regulated oncogenes Gli1 and Gli2 block myoblast differentiation by inhibiting MyoD-mediated transcriptional activation. Oncogene 2007; 26: 1122-1136.
7. Kapadia SB, Meis JM, Frisman DM, et al. Fetal rhabdomyoma of the head and neck: a clinicopathologic and immunophenotypic study of 24 cases. Hum Pathol 1993; 24: 754-765.
8. Klijanienko J, Caillaud JM, Micheau C, et al. [Basal-cell nevomatosis associated with multifocal fetal rhabdomyoma. A case]. Presse Med 1988; 17: 2247-2250.
9. Kodet R, Fajstavr J, Kabelka Z, et al. Is fetal cellular rhabdomyoma an entity or a differentiated rhabdomyosarcoma? A study of patients with rhabdomyoma of the tongue and sarcoma of the tongue enrolled in the intergroup rhabdomyosarcoma studies I, II, and III. Cancer 1991; 67: 2907-2913.
10. Dahl I, Angervall L, Save-Soderbergh J. Foetal rhabdomyoma. Case report of a patient with two tumours. Acta Pathol Microbiol Scand A 1976; 84: 107-112.
11. Jacques SM, Lawrence WD, Malviya VK. Uterine mixed embryonal rhabdomyosarcoma and fetal rhabdomyoma. Gynecol Oncol 1993; 48: 272-276.
12. Rudnicki MA, Le Grand F, McKinnell I, et al. The molecular regulation of muscle stem cell function. Cold Spring Harb Symp Quant Biol 2008; 73: 323-331.
13. Tostar U, Malm CJ, Meis-Kindblom JM, et al. Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development. J Pathol 2006; 208: 17-25.
14. Boutet N, Bignon YJ, Drouin-Garraud V, et al. Spectrum of PTCH1 mutations in French patients with Gorlin syndrome. J Invest Dermatol 2003; 121: 478-481.
15. Lo Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis 2008; 3: 32.
16. Reinke LM, Xu Y, Cheng C. Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition. J Biol Chem 2012; 287: 36435-36442.
17. Yuan F, Song L, Qian L, et al. Assembling an orchestra: Fanconi anemia pathway of DNA repair. Front Biosci 2010; 15: 1131-1149.
18. Rajgor D, Mellad JA, Autore F, et al. Multiple novel nesprin-1 and nesprin-2 variants act as versatile tissue-specific intracellular scaffolds. PLoS One 2012; 7: e40098.
19. Kappler R, Bauer R, Calzada-Wack J, et al. Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma. Oncogene 2004; 23: 8785-8795.
20. Kodet R, Newton WA Jr, Hamoudi AB, et al. Orbital rhabdomyosarcomas and related tumors in childhood: relationship of morphology to prognosis-an Intergroup Rhabdomyosarcoma study. Med Pediatr Oncol 1997; 29: 51-60.
21. Bridge JA, Liu J, Weibolt V, et al. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study. Genes Chromosomes Cancer 2000; 27: 337-344.